Bioventus appoints John A. Bartholdson to board as Class II director effective Jan 8, 2023

Bioventus Inc.

John A. Bartholdson, 52, co-founder and Partner at Juniper Investment Company, appointed to Bioventus board effective Jan 8, 2023.
He will serve as Class II director until 2023 annual meeting or successor elected.
Bartholdson receives annual cash retainer of $55,000 and initial RSU award valued at $152,000.
He brings 25 years experience in private/public equity, currently chairs Theragenics board.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John A. Bartholdson

Class II Director

BVS · Bioventus Inc.

Effective: 2023-01-08
Filed: January 9, 2023, 6:59 PM ET

On January 8, 2023, the Board of Directors (the "Board") of Bioventus Inc. (the "Company") appointed John A. Bartholdson to the Board as a Class II director effective on January 8, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John A. Bartholdson was appointed as Class II Director at Bioventus Inc..

Action: appointed
Role: Class II Director

Exact text from the filing

On January 8, 2023, the Board of Directors (the "Board") of Bioventus Inc. (the "Company") appointed John A. Bartholdson to the Board as a Class II director effective on January 8, 2023.

View on SEC.gov

Bioventus Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-000737

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.